Similar articles

• Hypercholesterolemia after chemotherapy for testis cancer.

  Raghavan D, Cox K, Childs A, Grygiel J, Sullivan D. Raghavan D, et al. J Clin Oncol. 1992 Sep;10(9):1386-9. doi: 10.1200/JCO.1992.10.9.1386. J Clin Oncol. 1992. PMID: 1325540
• High dose chemotherapy with autologous stem cell transplantation for patients with germ-cell cancer.

  Popovic L, Jovanovic D, Donat D, Petrovic D, Roganovic T, Lotz JP. Popovic L, et al. J BUON. 2013 Jan-Mar;18(1):290-1. J BUON. 2013. PMID: 23613419 No abstract available.
• Fertility after chemotherapy for ovarian germ cell tumors.

  Rustin GJ, Newlands ES, Begent RH, Bagshawe KD. Rustin GJ, et al. J Clin Oncol. 1988 Sep;6(9):1520-1. J Clin Oncol. 1988. PMID: 2843612 No abstract available.
• Late toxicities, long-term follow-up, less intensive treatment: leading issues in the therapy of testis cancer.

  Kantoff PW, Garnick MB. Kantoff PW, et al. J Clin Oncol. 1988 Aug;6(8):1216-9. doi: 10.1200/JCO.1988.6.8.1216. J Clin Oncol. 1988. PMID: 2842462 Review. No abstract available.
• The chemotherapy of disseminated testicular non-seminomatous germ cell tumors and the clinical research of the EORTC Genitourinary Group.

  Stoter G, Denis L. Stoter G, et al. Acta Urol Belg. 1985;53(2):428-40. Acta Urol Belg. 1985. PMID: 2409785 Review. English, French. No abstract available.